1 Market Overview

• 1.1 Product Overview and Scope
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Market Analysis by Type
  • 1.3.1 Overview: Global Methylene Blue Enteric-coated Sustained-release Tablets Consumption Value by Type: 2021 Versus 2025 Versus 2032
  • 1.3.2 25 mg
  • 1.3.3 50 mg
• 1.4 Market Analysis by Dosage Form
  • 1.4.1 Overview: Global Methylene Blue Enteric-coated Sustained-release Tablets Consumption Value by Dosage Form: 2021 Versus 2025 Versus 2032
  • 1.4.2 Enteric-coated Sustained-release Tablets
  • 1.4.3 Colon-targeted Sustained-release Solid Preparation
• 1.5 Market Analysis by Sales Channel
  • 1.5.1 Overview: Global Methylene Blue Enteric-coated Sustained-release Tablets Consumption Value by Sales Channel: 2021 Versus 2025 Versus 2032
  • 1.5.2 Hospital
  • 1.5.3 Retail
  • 1.5.4 Online
• 1.6 Market Analysis by Application
  • 1.6.1 Overview: Global Methylene Blue Enteric-coated Sustained-release Tablets Consumption Value by Application: 2021 Versus 2025 Versus 2032
  • 1.6.2 Colorectal Lesion Screening
  • 1.6.3 Intestinal Mucosa Staining Imaging
  • 1.6.4 Others
• 1.7 Global Methylene Blue Enteric-coated Sustained-release Tablets Market Size & Forecast
  • 1.7.1 Global Methylene Blue Enteric-coated Sustained-release Tablets Consumption Value (2021 & 2025 & 2032)
  • 1.7.2 Global Methylene Blue Enteric-coated Sustained-release Tablets Sales Quantity (2021-2032)
  • 1.7.3 Global Methylene Blue Enteric-coated Sustained-release Tablets Average Price (2021-2032)

2 Manufacturers Profiles

• 2.1 Cosmo Pharmaceuticals NV
  • 2.1.1 Cosmo Pharmaceuticals NV Details
  • 2.1.2 Cosmo Pharmaceuticals NV Major Business
  • 2.1.3 Cosmo Pharmaceuticals NV Methylene Blue Enteric-coated Sustained-release Tablets Product and Services
  • 2.1.4 Cosmo Pharmaceuticals NV Methylene Blue Enteric-coated Sustained-release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.1.5 Cosmo Pharmaceuticals NV Recent Developments/Updates

3 Competitive Environment: Methylene Blue Enteric-coated Sustained-release Tablets by Manufacturer

• 3.1 Global Methylene Blue Enteric-coated Sustained-release Tablets Sales Quantity by Manufacturer (2021-2026)
• 3.2 Global Methylene Blue Enteric-coated Sustained-release Tablets Revenue by Manufacturer (2021-2026)
• 3.3 Global Methylene Blue Enteric-coated Sustained-release Tablets Average Price by Manufacturer (2021-2026)
• 3.4 Market Share Analysis (2025)
  • 3.4.1 Producer Shipments of Methylene Blue Enteric-coated Sustained-release Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2025
  • 3.4.2 Top 3 Methylene Blue Enteric-coated Sustained-release Tablets Manufacturer Market Share in 2025
  • 3.4.3 Top 6 Methylene Blue Enteric-coated Sustained-release Tablets Manufacturer Market Share in 2025
• 3.5 Methylene Blue Enteric-coated Sustained-release Tablets Market: Overall Company Footprint Analysis
  • 3.5.1 Methylene Blue Enteric-coated Sustained-release Tablets Market: Region Footprint
  • 3.5.2 Methylene Blue Enteric-coated Sustained-release Tablets Market: Company Product Type Footprint
  • 3.5.3 Methylene Blue Enteric-coated Sustained-release Tablets Market: Company Product Application Footprint
• 3.6 New Market Entrants and Barriers to Market Entry
• 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

• 4.1 Global Methylene Blue Enteric-coated Sustained-release Tablets Market Size by Region
  • 4.1.1 Global Methylene Blue Enteric-coated Sustained-release Tablets Sales Quantity by Region (2021-2032)
  • 4.1.2 Global Methylene Blue Enteric-coated Sustained-release Tablets Consumption Value by Region (2021-2032)
  • 4.1.3 Global Methylene Blue Enteric-coated Sustained-release Tablets Average Price by Region (2021-2032)
• 4.2 North America Methylene Blue Enteric-coated Sustained-release Tablets Consumption Value (2021-2032)
• 4.3 Europe Methylene Blue Enteric-coated Sustained-release Tablets Consumption Value (2021-2032)
• 4.4 Asia-Pacific Methylene Blue Enteric-coated Sustained-release Tablets Consumption Value (2021-2032)
• 4.5 South America Methylene Blue Enteric-coated Sustained-release Tablets Consumption Value (2021-2032)
• 4.6 Middle East & Africa Methylene Blue Enteric-coated Sustained-release Tablets Consumption Value (2021-2032)

5 Market Segment by Type

• 5.1 Global Methylene Blue Enteric-coated Sustained-release Tablets Sales Quantity by Type (2021-2032)
• 5.2 Global Methylene Blue Enteric-coated Sustained-release Tablets Consumption Value by Type (2021-2032)
• 5.3 Global Methylene Blue Enteric-coated Sustained-release Tablets Average Price by Type (2021-2032)

6 Market Segment by Application

• 6.1 Global Methylene Blue Enteric-coated Sustained-release Tablets Sales Quantity by Application (2021-2032)
• 6.2 Global Methylene Blue Enteric-coated Sustained-release Tablets Consumption Value by Application (2021-2032)
• 6.3 Global Methylene Blue Enteric-coated Sustained-release Tablets Average Price by Application (2021-2032)

7 North America

• 7.1 North America Methylene Blue Enteric-coated Sustained-release Tablets Sales Quantity by Type (2021-2032)
• 7.2 North America Methylene Blue Enteric-coated Sustained-release Tablets Sales Quantity by Application (2021-2032)
• 7.3 North America Methylene Blue Enteric-coated Sustained-release Tablets Market Size by Country
  • 7.3.1 North America Methylene Blue Enteric-coated Sustained-release Tablets Sales Quantity by Country (2021-2032)
  • 7.3.2 North America Methylene Blue Enteric-coated Sustained-release Tablets Consumption Value by Country (2021-2032)
  • 7.3.3 United States Market Size and Forecast (2021-2032)
  • 7.3.4 Canada Market Size and Forecast (2021-2032)
  • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

• 8.1 Europe Methylene Blue Enteric-coated Sustained-release Tablets Sales Quantity by Type (2021-2032)
• 8.2 Europe Methylene Blue Enteric-coated Sustained-release Tablets Sales Quantity by Application (2021-2032)
• 8.3 Europe Methylene Blue Enteric-coated Sustained-release Tablets Market Size by Country
  • 8.3.1 Europe Methylene Blue Enteric-coated Sustained-release Tablets Sales Quantity by Country (2021-2032)
  • 8.3.2 Europe Methylene Blue Enteric-coated Sustained-release Tablets Consumption Value by Country (2021-2032)
  • 8.3.3 Germany Market Size and Forecast (2021-2032)
  • 8.3.4 France Market Size and Forecast (2021-2032)
  • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
  • 8.3.6 Russia Market Size and Forecast (2021-2032)
  • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

• 9.1 Asia-Pacific Methylene Blue Enteric-coated Sustained-release Tablets Sales Quantity by Type (2021-2032)
• 9.2 Asia-Pacific Methylene Blue Enteric-coated Sustained-release Tablets Sales Quantity by Application (2021-2032)
• 9.3 Asia-Pacific Methylene Blue Enteric-coated Sustained-release Tablets Market Size by Region
  • 9.3.1 Asia-Pacific Methylene Blue Enteric-coated Sustained-release Tablets Sales Quantity by Region (2021-2032)
  • 9.3.2 Asia-Pacific Methylene Blue Enteric-coated Sustained-release Tablets Consumption Value by Region (2021-2032)
  • 9.3.3 China Market Size and Forecast (2021-2032)
  • 9.3.4 Japan Market Size and Forecast (2021-2032)
  • 9.3.5 South Korea Market Size and Forecast (2021-2032)
  • 9.3.6 India Market Size and Forecast (2021-2032)
  • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
  • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

• 10.1 South America Methylene Blue Enteric-coated Sustained-release Tablets Sales Quantity by Type (2021-2032)
• 10.2 South America Methylene Blue Enteric-coated Sustained-release Tablets Sales Quantity by Application (2021-2032)
• 10.3 South America Methylene Blue Enteric-coated Sustained-release Tablets Market Size by Country
  • 10.3.1 South America Methylene Blue Enteric-coated Sustained-release Tablets Sales Quantity by Country (2021-2032)
  • 10.3.2 South America Methylene Blue Enteric-coated Sustained-release Tablets Consumption Value by Country (2021-2032)
  • 10.3.3 Brazil Market Size and Forecast (2021-2032)
  • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

• 11.1 Middle East & Africa Methylene Blue Enteric-coated Sustained-release Tablets Sales Quantity by Type (2021-2032)
• 11.2 Middle East & Africa Methylene Blue Enteric-coated Sustained-release Tablets Sales Quantity by Application (2021-2032)
• 11.3 Middle East & Africa Methylene Blue Enteric-coated Sustained-release Tablets Market Size by Country
  • 11.3.1 Middle East & Africa Methylene Blue Enteric-coated Sustained-release Tablets Sales Quantity by Country (2021-2032)
  • 11.3.2 Middle East & Africa Methylene Blue Enteric-coated Sustained-release Tablets Consumption Value by Country (2021-2032)
  • 11.3.3 Turkey Market Size and Forecast (2021-2032)
  • 11.3.4 Egypt Market Size and Forecast (2021-2032)
  • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
  • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

• 12.1 Methylene Blue Enteric-coated Sustained-release Tablets Market Drivers
• 12.2 Methylene Blue Enteric-coated Sustained-release Tablets Market Restraints
• 12.3 Methylene Blue Enteric-coated Sustained-release Tablets Trends Analysis
• 12.4 Porters Five Forces Analysis
  • 12.4.1 Threat of New Entrants
  • 12.4.2 Bargaining Power of Suppliers
  • 12.4.3 Bargaining Power of Buyers
  • 12.4.4 Threat of Substitutes
  • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

• 13.1 Raw Material of Methylene Blue Enteric-coated Sustained-release Tablets and Key Manufacturers
• 13.2 Manufacturing Costs Percentage of Methylene Blue Enteric-coated Sustained-release Tablets
• 13.3 Methylene Blue Enteric-coated Sustained-release Tablets Production Process
• 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

• 14.1 Sales Channel
  • 14.1.1 Direct to End-User
  • 14.1.2 Distributors
• 14.2 Methylene Blue Enteric-coated Sustained-release Tablets Typical Distributors
• 14.3 Methylene Blue Enteric-coated Sustained-release Tablets Typical Customers

15 Research Findings and Conclusion

16 Appendix

• 16.1 Methodology
• 16.2 Research Process and Data Source

According to our (Global Info Research) latest study, the global Methylene Blue Enteric-coated Sustained-release Tablets market size was valued at US$ 16.26 million in 2025 and is forecast to a readjusted size of US$ 40.36 million by 2032 with a CAGR of 5.5% during review period.
Methylene Blue Enteric-coated Sustained-release Tablets are solid enteric-coated and sustained-release preparations with methylene blue as the main active ingredient. Adopting combined technologies of enteric coating and sustained-release formulation, the drug avoids decomposition and destruction in the stomach, enabling the active ingredients to be released slowly and continuously in a targeted manner in the intestinal tract. With a unique targeted staining effect, it is mainly applied in colonoscopy examinations to improve the identification of intestinal mucosal lesions and assist the early screening and diagnosis of tiny colorectal lesions. The sustained-release dosage form steadily controls the drug release rate, reduces local irritation, and improves medication safety and tolerability, providing important auxiliary medication support for the accurate clinical diagnosis and treatment of intestinal diseases.In 2025, global production of Methylene Blue Enteric-coated Sustained-release Tablets reached approximately 2.1 million bottles.
Methylene Blue Enteric-coated Sustained-release Tablets, as the world’s first oral colon-targeted staining diagnostic preparation, has become a key product in the field of early colorectal cancer screening by virtue of its unique enteric-coated and sustained-release technology and prominent clinical value. Originally developed by Cosmo Pharma, it was first launched in the European Union and later introduced and approved in China by C&P Pharmaceutical, filling the domestic gap in oral diagnostic drugs for intestinal staining. With the rising global incidence of colorectal cancer and growing awareness of early screening, the demand for colonoscopy continues to expand, creating broad market prospects for this product. Compared with traditional intraoperative staining methods, this drug features convenient oral administration and can be taken simultaneously during intestinal preparation, greatly improving examination efficiency and patient compliance. Its clinical advantages lie in precisely staining the intestinal mucosa, elevating the detection rate of minute and flat lesions, facilitating early clinical intervention and optimizing patient prognosis. At present, the market competition pattern remains favorable. Supported by patented technologies and first-mover advantages, the product has formed high market barriers. With the continuous promotion of clinical indications and the expected inclusion in medical insurance, its market penetration is projected to increase steadily in the future, making it a vital growth driver in the field of intestinal disease diagnosis.
This report is a detailed and comprehensive analysis for global Methylene Blue Enteric-coated Sustained-release Tablets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Methylene Blue Enteric-coated Sustained-release Tablets market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Methylene Blue Enteric-coated Sustained-release Tablets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Methylene Blue Enteric-coated Sustained-release Tablets market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Methylene Blue Enteric-coated Sustained-release Tablets market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Methylene Blue Enteric-coated Sustained-release Tablets
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Methylene Blue Enteric-coated Sustained-release Tablets market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cosmo Pharmaceuticals NV, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Methylene Blue Enteric-coated Sustained-release Tablets market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
25 mg
50 mg
Market segment by Dosage Form
Enteric-coated Sustained-release Tablets
Colon-targeted Sustained-release Solid Preparation
Market segment by Sales Channel
Hospital
Retail
Online
Market segment by Application
Colorectal Lesion Screening
Intestinal Mucosa Staining Imaging
Others
Major players covered
Cosmo Pharmaceuticals NV
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Methylene Blue Enteric-coated Sustained-release Tablets product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Methylene Blue Enteric-coated Sustained-release Tablets, with price, sales quantity, revenue, and global market share of Methylene Blue Enteric-coated Sustained-release Tablets from 2021 to 2026.
Chapter 3, the Methylene Blue Enteric-coated Sustained-release Tablets competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Methylene Blue Enteric-coated Sustained-release Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Methylene Blue Enteric-coated Sustained-release Tablets market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Methylene Blue Enteric-coated Sustained-release Tablets.
Chapter 14 and 15, to describe Methylene Blue Enteric-coated Sustained-release Tablets sales channel, distributors, customers, research findings and conclusion.